Core Viewpoint - The stock of BeiYikang (920199) experienced a rise of 1.80% with a turnover rate of 27.17%, indicating significant trading activity and interest from institutional investors [2] Trading Activity - The total trading volume for BeiYikang reached 5.79 billion yuan, with a price fluctuation of 17.39% throughout the day [2] - Institutional investors net bought 3.43 million yuan, while brokerage seats collectively net sold 30.22 million yuan [2] - The stock was listed on the daily trading board due to its turnover rate of 27.17% [2] Institutional Participation - Among the top five trading departments, the total transaction volume was 128 million yuan, with a buying amount of 50.65 million yuan and a selling amount of 77.45 million yuan, resulting in a net sell of 26.79 million yuan [2] - One institutional seat was noted in the trading data, with a net buy of 3.43 million yuan, buying 8.68 million yuan and selling 5.25 million yuan [2] Historical Performance - Over the past six months, BeiYikang has appeared on the trading board nine times, with an average price increase of 4.03% the day after being listed and an average increase of 1.04% over the following five days [2]

Group 1 - The report highlights the significant progress in the pharmaceutical and healthcare system reforms during the "14th Five-Year Plan" period, with a focus on grassroots healthcare and urban-rural integration [1][12] - The "15th Five-Year Plan" emphasizes the support for innovative drugs and medical devices, aiming to enhance the healthcare system and promote the development of traditional Chinese medicine [1][17] - The report indicates that the 11th batch of national drug procurement successfully implemented innovative goals, including maintaining clinical stability and quality assurance [1][14] Group 2 - As of December 31, 2025, the total market capitalization of 21 pharmaceutical and biotechnology companies on the North Exchange reached 748.30 billion, reflecting a growth of 45.81% from the beginning of the year [2][20] - The average market capitalization of these companies increased to 35.63 billion, up 38.87% from the previous year [2][21] - The North Exchange's pharmaceutical sector is primarily composed of chemical pharmaceuticals (38.10%), medical devices (28.57%), and biological products (19.05%) [2][31] Group 3 - In 2025, the North Exchange's pharmaceutical and biotechnology sector experienced a year-on-year increase of 37.38%, ranking third among various sectors [3][54] - The report notes that 80.95% of the pharmaceutical companies on the North Exchange saw an increase in their stock prices throughout the year [3][42] - The top-performing companies in terms of stock price growth included JinHao Medical (+174.08%), NuoSiLanDe (+105.64%), and BeiYiKang (+76.39%) [3][45] Group 4 - The report indicates that the North Exchange's pharmaceutical companies had a PE TTM average of 73X by the end of 2025, with a peak of 119X in August [2][34] - The distribution of valuations shows that the North Exchange has a higher proportion of companies with significant losses compared to other exchanges, with 28.57% of companies in the loss category [2][40] - The report highlights that the North Exchange's pharmaceutical sector is characterized by a high concentration of companies in the 100X and above PE TTM range [2][43]

Group 1 - The core point of the news is that Beiyikang (stock code: 920199) was listed on the Longhu list on January 7, 2026, due to a significant trading activity, with a turnover rate of 33.29% and a transaction volume of 12.302 million shares, amounting to 752 million yuan [1][2][3] Group 2 - The top buying seat was from Guotai Junan Securities Co., Ltd., Shanghai Sipin Road branch, with a purchase amount of approximately 14.82 million yuan [2] - The top selling seat was from China Galaxy Securities Co., Ltd., Xingtai Metallurgical North Road branch, with a selling amount of approximately 30.26 million yuan [2] - Other notable buying and selling activities included multiple branches of Dongfang Caifu Securities and CITIC Jiantou Securities, indicating a diverse trading interest in Beiyikang [2]

Core Insights - The North Exchange 50 index increased by 1.82% to close at 1,493.04 points on January 6, 2026, with a trading volume of 259.89 billion yuan and a turnover rate of 3.97% [3][4][6] - The overall valuation of the North Exchange is at 47.74 times earnings, which is higher than the valuations of the ChiNext and STAR Market [3][10] - The sectors that performed well include non-ferrous metals (+11.1%), home appliances (+4.5%), computers (+4.4%), and machinery (+3.0%), while the pharmaceutical sector saw a decline of 0.5% [3][4] Trading Performance - On January 6, 2026, the North Exchange had a total market capitalization of 903.76 billion yuan, with 396.77 billion shares listed, of which 253.49 billion shares were tradable [3][4] - The average daily trading volume for the previous week was 194.04 billion yuan, indicating a recovery in trading levels on January 6 [3][4] Stock Performance - Among the 287 listed companies, 264 saw an increase in stock prices, while 21 experienced declines. Notable gainers included Hanxin Technology (+29.99%) and Tianli Composite (+29.99%), while Jin Hao Medical saw a significant drop of 14.57% [3][8][9] - The top ten stocks by market performance on January 6 included Hanxin Technology, Tianli Composite, and Beiyikang, with respective market capitalizations of 30.35 billion yuan, 95.63 billion yuan, and 39.80 billion yuan [8][9] Valuation Analysis - The average price-to-earnings (P/E) ratio for companies on the North Exchange is 47.74 times, with the highest sector being non-ferrous metals at 126.1 times, followed by home appliances at 92.8 times and food and beverage at 81.7 times [3][10] - The valuation of the North Exchange continues to be higher than that of the ChiNext, which has a P/E ratio of 44.85 times [3][10] Sector Performance - The non-ferrous metals sector showed the highest increase in stock prices, reflecting strong market interest and potential growth opportunities [3][4] - The pharmaceutical sector, in contrast, faced challenges, as indicated by the decline in stock prices, suggesting potential issues within the industry [3][4][9]

四川千里倍益康医疗科技股份有限公司股票交易异常波动公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带法律责任。 证券代码：920199 证券简称:倍益康 公告编号：2026-001 三、是否存在应披露而未披露的重大信息的声明 本公司董事会确认，本公司没有任何根据《北京证券交易所股票上市规则》 等有关规定应披露而未披露的事项或与该事项有关的筹划、商谈、意向、协议等， 董事会也未获悉本公司有根据《北京证券交易所股票上市规则》等有关规定应披 露而未披露的、对本公司股票交易价格产生较大影响的信息。 公司控股股东、实际控制人及一致行动人，持股 5%以上股东，在任的董事 及高级管理人员。 一、股票交易异常波动的具体情况 2、 核实方式： 公司股票最近 2 个有成交的交易日（2026 年 1 月 5 日至 2026 年 1 月 6 日） 以内收盘价涨幅偏离值累计达到 65.30%，根据《北京证券交易所交易规则（试 行》的有关规定，属于股票交易异常波动情形。 电话询问、口头询问、微信询问等方式。 二、公司关注并核实的相关情况 3 ...

Group 1 - The stock of BeiYikang (920199) reached the daily limit, with a turnover rate of 9.27% and a transaction amount of 200 million yuan [2] - The stock was listed on the North Exchange's daily limit due to a price increase of 29.98%, with a net buying amount of 2.6089 million yuan from brokerage seats [2] - The top five brokerage seats accounted for a total transaction amount of 95.5737 million yuan, with a buying amount of 49.0913 million yuan and a selling amount of 46.4824 million yuan, resulting in a net buying of 2.6089 million yuan [2] Group 2 - The largest buying brokerage was Guotou Securities Co., Ltd. with a purchase amount of 14.6158 million yuan, while the largest selling brokerage was CITIC Construction Investment Securities Co., Ltd. with a selling amount of 15.6595 million yuan [2] - Over the past six months, the stock has appeared on the daily limit list seven times, with an average price increase of 5.86% the day after being listed and an average increase of 2.23% in the following five days [2]

Summary of Key Points Core Viewpoint The trading volume and value of stocks on the Beijing Stock Exchange (BSE) saw significant increases on January 6, with a total trading volume of 1.007 billion shares and a trading value of 26.037 billion yuan, marking an increase of 4.849 billion yuan compared to the previous trading day. The majority of stocks experienced price increases, indicating a positive market sentiment. Trading Performance - Total trading volume reached 1.007 billion shares, with a trading value of 26.037 billion yuan, an increase of 4.849 billion yuan from the previous day [1]. - Out of the tradable stocks, 264 stocks closed higher, accounting for 92.31% of the total, while only 21 stocks closed lower [1]. - Notable gainers included Guoyuan Technology, Haixi Communications, and Dapeng Industrial, with increases of 24.30%, 16.85%, and 15.90% respectively [1]. - The stocks with the highest trading value included Hengtong Technology, Tianli Composite, and Nacono, with trading values of 1.387 billion yuan, 1.107 billion yuan, and 628.275 million yuan respectively [1]. Stock Activity - A total of 68 stocks had trading volumes exceeding 100 million yuan, indicating high trading activity [1]. - The turnover rate for stocks was notably high, with 31 stocks having turnover rates exceeding 10%, and 6 stocks exceeding 20% [1]. - The stocks with the highest turnover rates included Dapeng Industrial, Jinhao Medical, and Hanxin Technology, with rates of 42.72%, 32.55%, and 25.42% respectively [1].

Core Viewpoint - BeiYikang (920199) experienced a trading halt today, reaching a daily limit increase of 29.98%, with a turnover rate of 12.94% and a total transaction amount of 213 million yuan [2] Trading Activity - The stock was listed on the Longhu list due to its daily price fluctuation limit, with a net buying amount of 12.91 million yuan from brokerage seats [2] - The top five brokerage seats accounted for a total transaction amount of 86.39 million yuan, with a buying amount of 49.65 million yuan and a selling amount of 36.74 million yuan, resulting in a net buying of 12.91 million yuan [2] - The largest buying brokerage was CITIC Securities Co., Ltd. Nanchang Beijing East Road Securities Brokerage, with a buying amount of 12.11 million yuan, while the largest selling brokerage was China Galaxy Securities Co., Ltd. Xingtai Metallurgical North Road Securities Brokerage, with a selling amount of 9.60 million yuan [2] Historical Performance - Over the past six months, BeiYikang has appeared on the Longhu list six times, with an average price increase of 1.04% the day after being listed and an average decline of 3.32% in the following five days [2]

Summary of Key Points Core Viewpoint The trading volume and value of stocks on the Beijing Stock Exchange (BSE) showed a significant increase on January 5, with a total trading volume of 803 million shares and a total trading value of 21.188 billion yuan, marking an increase of 474 million yuan compared to the previous trading day. The majority of stocks experienced price increases, indicating a positive market sentiment. Trading Performance - The total trading volume on the BSE reached 803 million shares, with a trading value of 21.188 billion yuan, an increase of 474 million yuan from the previous day [1] - A total of 226 stocks closed higher, accounting for 79.02% of the tradable stocks, with notable gainers including KaiDe Quartz (up 22.36%), JinHao Medical (up 20.03%), and HengDong Light (up 12.94%) [1] - Conversely, 57 stocks closed lower, with TianMing Technology, JiaXian Co., and LiFang Holdings experiencing the largest declines of 15.03%, 10.33%, and 8.46% respectively [1] Active Stocks - 56 stocks had a trading value exceeding 100 million yuan, with HengDong Light leading at 1.909 billion yuan, followed by XingTu Measurement Control at 736 million yuan and KaiDe Quartz at 477 million yuan [1] - The trading activity was robust, with 23 stocks having a turnover rate exceeding 10%, and 5 stocks exceeding 20% [1] - The stocks with the highest turnover rates included DaPeng Industrial (28.25%), HengDong Light (27.83%), and ChenGuang Medical (24.13%) [1] Notable Stock Data - The closing prices and performance of key stocks included: - HengDong Light: 348.99 yuan, up 12.94%, turnover rate 27.83%, trading value 1.909 billion yuan [1] - XingTu Measurement Control: 90.50 yuan, up 7.10%, turnover rate 19.74%, trading value 736 million yuan [1] - KaiDe Quartz: 47.28 yuan, up 22.36%, turnover rate 18.24%, trading value 477 million yuan [1]

Core Viewpoint - On January 5, 2026, Beiyikang (920199) experienced a significant stock price increase of 29.98%, leading to its appearance on the trading leaderboard with a trading volume of 4.7824 million shares and a transaction value of 213 million yuan [1][2]. Group 1: Trading Performance - Beiyikang's closing price reached 44.96 yuan, marking a notable increase in its stock value [1]. - The total trading volume for the day was 4.7824 million shares, with a total transaction amount of 213 million yuan [1]. - The top buying seat was from CITIC Jiantou Securities Co., Ltd., Nanchang Beijing East Road Securities Business Department, which purchased shares worth approximately 12.11 million yuan [2]. Group 2: Trading Participants - The second largest buyer was CITIC Jiantou Securities Co., Ltd., Huzhou People's Road Securities Business Department, with a purchase amount of approximately 12.05 million yuan [2]. - The largest selling seat was from China Galaxy Securities Co., Ltd., Xingtai Metallurgy North Road Securities Business Department, which sold shares worth approximately 9.60 million yuan [2]. - Other notable selling participants included Guotai Junan Securities Co., Ltd. and Xinda Securities Co., Ltd., with significant sell amounts recorded [2].